InVivo Therapeutics Holdings Current Ratio 2010-2023 | NVIVQ
InVivo Therapeutics Holdings current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| InVivo Therapeutics Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-09-30 | $0.01B | $0.00B | 14.30 |
| 2023-06-30 | $0.01B | $0.00B | 9.14 |
| 2023-03-31 | $0.02B | $0.00B | 8.85 |
| 2022-12-31 | $0.02B | $0.00B | 7.27 |
| 2022-09-30 | $0.01B | $0.00B | 4.62 |
| 2022-06-30 | $0.01B | $0.00B | 5.64 |
| 2022-03-31 | $0.02B | $0.00B | 7.70 |
| 2021-12-31 | $0.02B | $0.00B | 7.33 |
| 2021-09-30 | $0.02B | $0.00B | 10.64 |
| 2021-06-30 | $0.02B | $0.00B | 13.10 |
| 2021-03-31 | $0.03B | $0.00B | 17.30 |
| 2020-12-31 | $0.02B | $0.00B | 9.97 |
| 2020-09-30 | $0.01B | $0.00B | 4.38 |
| 2020-06-30 | $0.01B | $0.00B | 5.77 |
| 2020-03-31 | $0.01B | $0.00B | 5.33 |
| 2019-12-31 | $0.01B | $0.00B | 2.55 |
| 2019-09-30 | $0.01B | $0.00B | 4.01 |
| 2019-06-30 | $0.01B | $0.00B | 5.72 |
| 2019-03-31 | $0.01B | $0.00B | 6.86 |
| 2018-12-31 | $0.02B | $0.00B | 7.77 |
| 2018-09-30 | $0.02B | $0.00B | 6.93 |
| 2018-06-30 | $0.02B | $0.03B | 0.92 |
| 2018-03-31 | $0.01B | $0.00B | 3.20 |
| 2017-12-31 | $0.01B | $0.00B | 4.44 |
| 2017-09-30 | $0.02B | $0.00B | 5.05 |
| 2017-06-30 | $0.02B | $0.00B | 5.89 |
| 2017-03-31 | $0.03B | $0.00B | 6.67 |
| 2016-12-31 | $0.03B | $0.01B | 6.98 |
| 2016-09-30 | $0.04B | $0.01B | 6.98 |
| 2016-06-30 | $0.04B | $0.01B | 9.23 |
| 2016-03-31 | $0.05B | $0.01B | 9.76 |
| 2015-12-31 | $0.02B | $0.00B | 6.26 |
| 2015-09-30 | $0.02B | $0.01B | 4.11 |
| 2015-06-30 | $0.03B | $0.01B | 2.50 |
| 2015-03-31 | $0.03B | $0.02B | 1.68 |
| 2014-12-31 | $0.02B | $0.01B | 1.70 |
| 2014-09-30 | $0.02B | $0.01B | 3.81 |
| 2014-06-30 | $0.02B | $0.01B | 2.78 |
| 2014-03-31 | $0.01B | $0.00B | 5.29 |
| 2013-12-31 | $0.02B | $0.00B | 6.44 |
| 2013-09-30 | $0.02B | $0.00B | 9.10 |
| 2013-06-30 | $0.02B | $0.00B | 14.81 |
| 2013-03-31 | $0.01B | $0.03B | 0.42 |
| 2012-12-31 | $0.01B | $0.02B | 0.81 |
| 2012-09-30 | $0.02B | $0.01B | 1.27 |
| 2012-06-30 | $0.02B | $0.03B | 0.78 |
| 2012-03-31 | $0.02B | $0.03B | 0.70 |
| 2011-12-31 | $0.01B | $0.04B | 0.14 |
| 2011-09-30 | $0.00B | $0.01B | 0.78 |
| 2011-06-30 | $0.01B | $0.01B | 0.54 |
| 2011-03-31 | $0.01B | $0.01B | 0.68 |
| 2010-12-31 | $0.01B | $0.01B | 0.81 |
| 2010-09-30 | $0.00B | $0.00B | 0.17 |
| 2010-06-30 | $0.00B | $0.00B | 0.39 |
| 2010-03-31 | $0.00B | $0.00B | 0.00 |
| 2009-12-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | $0.00B | 0.00 |
| 2009-06-30 | $0.00B | $0.00B | 0.86 |
| 2009-03-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $223.656B | 26.24 |
| Boston Scientific (BSX) | United States | $157.946B | 37.72 |
| Stryker (SYK) | United States | $152.832B | 31.96 |
| EssilorLuxottica (ESLOY) | France | $137.378B | 0.00 |
| Medtronic (MDT) | Ireland | $117.532B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.462B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.306B | 24.72 |
| ResMed (RMD) | United States | $40.680B | 30.56 |
| Agilent Technologies (A) | United States | $33.534B | 21.86 |
| GE HealthCare Technologies (GEHC) | United States | $32.803B | 15.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.816B | 17.08 |
| Terumo (TRUMY) | Japan | $25.125B | 32.63 |
| Insulet (PODD) | United States | $20.991B | 82.39 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.463B | 11.86 |
| Baxter (BAX) | United States | $14.395B | 10.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.805B | 23.68 |
| Lantheus Holdings (LNTH) | United States | $4.970B | 12.54 |
| Perrigo (PRGO) | Ireland | $3.781B | 9.58 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.644B | 16.60 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.383B | 28.11 |
| ICU Medical (ICUI) | United States | $3.088B | 22.77 |
| LeMaitre Vascular (LMAT) | United States | $1.852B | 41.40 |
| AtriCure (ATRC) | United States | $1.739B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.643B | 11.30 |
| Acuren (TIC) | United States | $1.391B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.271B | 28.60 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Phibro Animal Health (PAHC) | United States | $1.132B | 14.47 |
| BioLife Solutions (BLFS) | United States | $1.044B | 0.00 |
| Neogen (NEOG) | United States | $1.019B | 16.19 |
| Curaleaf Holdings (CURLF) | Canada | $0.939B | 0.00 |
| InMode (INMD) | Israel | $0.879B | 8.13 |
| Kestra Medical Technologies (KMTS) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.651B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.578B | 0.00 |
| Owens & Minor (OMI) | United States | $0.549B | 4.56 |
| CeriBell (CBLL) | United States | $0.539B | 0.00 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.526B | 20.52 |
| SNDL (SNDL) | Canada | $0.378B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.374B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.307B | 11.29 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.254B | 75.33 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 20.60 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Biote (BTMD) | United States | $0.237B | 6.68 |
| Sanara MedTech (SMTI) | United States | $0.223B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.75 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.215B | 0.00 |
| Exagen (XGN) | United States | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.07 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.37 |
| Jushi Holdings (JUSHF) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.62 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| United-Guardian (UG) | United States | $0.036B | 12.51 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |